Abstract: Prevented and preventable fractions have been widely used in medical science to evaluate the proportion of new diseases that can be averted by a protective exposure. However, most existing formulas used in practical situations cannot be interpreted as proportions without any further assumptions because they are obtained according to different target populations and may fall outside the range [0.000, 1.000]. To solve this problem, this paper proposes counterfactual-based prevented and preventable proportions. When both causal effects and observed probabilities are available, we show that the proposed measures are identifiable under the negative monotonicity assumption. Additionally, when the negative monotonicity assumption is violated, we formulate the bounds on the proposed measures. We also show that negative monotonicity together with exogeneity induces equivalence between the proposed measures and existing measures.
Introduction
In medical science, one of important issues is to assess how much a disease can be averted by a protective exposure, in subjects that would otherwise suffer from the disease. For example, in a 1970 measles epidemic in Texarkana, Texas, USA, some diseases occurred in children who had been vaccinated against measles. At that time, the public questioned the effectiveness of the measles vaccine and Landrioan [1] reported that its efficacy was 95.9%. According to Gregg [2] , this implies that vaccination prevented 96% of diseases that would have occurred in vaccinated children, had they not been vaccinated. In a 2004 varicella outbreak in Nebraska, USA, some diseases occurred in children who had been vaccinated against varicella and the Centers for Disease Control and Prevention [3] reported that the vaccine's effectiveness was approximately 81%. According to Gregg [2] , this implies that vaccination prevented approximately 80% of diseases that would have occurred in vaccinated children, had they not been vaccinated.
To measure such an impact in vaccine trials, Greenwood and Yule [4] proposed vaccine efficacy, which is defined as the proportion of undiseased subjects in the vaccinated group who, under ideal conditions, would become diseased if they had not been vaccinated. Weinberg and Szilagyi [5] stated that vaccine efficacy is best measured by double-blind, randomized, clinical controlled trials, such as those performed for the pentavalent and monovalent rotavirus vaccines. For exposures or interventions other than vaccines, vaccine efficacy is equivalent to the prevented fraction among the exposed [2] . In the field of epidemiology, Miettinen [6] formulated the prevented fraction to evaluate the effectiveness of a protective exposure. In biostatistics, Gargiullo et al. [7] proposed the variance estimator of the prevented fraction based on maximum likelihood theory for cross-sectional studies. Benichou [8] reviewed adjusted methods of estimating the prevented fraction and other ratio scales while controlling for other factors. Additionally, Laaksonen [9] discussed the calculation of the prevented fraction and its related measures based on a cohort study design. Recently, Greenland [10] discussed concepts and pitfalls in measuring and interpreting attributable fractions and prevented fractions. As observed from these vigorous discussions, the evaluation problem of vaccine efficacy and the prevented fraction is a classical topic, but remains of great interest in medical statistics even now.
When we reviewed early literature on the prevented fraction, we found that Miettinen [6] described one of the fundamental concepts of the prevented fraction that provides the motivation for this paper:
"the preventive (prevented) fraction is the proportion of cases prevented by the factor among the totality of cases that would have developed in the absence of the protective factor " [6] .
As seen from Miettinen's statement, the prevented fraction should be formulated based on the framework of causal inference, but it should not be considered within the framework of statistics routinely. In fact, Porta et al. [11, p. 224] and Boslaugh [12, p. 59 ] also stated "In a study of a total population, the prevented fraction of the incidence rate is computed as (I u -I p )/I u or P e (1 -I p /I u ), where I p is the rate of the disease in the population, I u is what the rate would be if everyone were not exposed, and P e is the prevalence of exposure" [11] . and "Whereas the denominators of attributable fractions are observable numbers of cases, the denominators of prevented fractions are nonobservable (counterfactual)" [12] .
However, to the best of our knowledge, most biostatistical researchers and practitioners do not appear to take this counterfactual aspect into account. Additionally, because measures in previous studies on the prevented fraction are formulated based on different target populations, they cannot be interpreted as proportions without any further assumptions and may fall outside the range [0.000, 1.000]. Similar to but different from the prevented fraction, according to Porta et al. [11, p. 223] , the preventable fraction is defined as the proportion of the disease in the population that would be prevented if the whole population were exposed to the factor. However, this measure is also formulated based on different target populations, and thus cannot be interpreted as a proportion.
To solve this problem, this paper defines prevented and preventable proportions based on the potential outcome model. The proposed measures are formulated based on a single target population and can be interpreted as proportions. Based on a similar motivation to ours, Suzuki et al. [13] reformulated the excess fraction, attributable fraction and etiologic fraction, and derived the bounds on these measures. However, they did not focus on the prevented and preventable fractions. Additionally, they derived their bounds under exogeneity. Conversely, we assume that both causal effects and observed probabilities are available. This assumption, which is weaker than exogeneity, enables us to evaluate the proposed measures when the causal effect is identifiable from observational studies, as well as experimental studies. In this situation, we show that the proposed measures are identifiable under the negative monotonicity assumption. When the negative monotonicity assumption is violated, we formulate the bounds within which the proposed measures must lie. The results show that the traditional prevented and preventable fractions under-evaluate the proposed measures under exogeneity assumption. Furthermore, we show that negative monotonicity together with exogeneity induces equivalence between the proposed measures and existing measures. The extensions to the case of multi-categorical exposure and the applications to experimental and observational studies are provided in the appendices.
Existing measures
Let X be a dichotomous protective exposure {x ′ (unexposed), x(exposed)} and Y be a dichotomous outcome {y ′ (undiseased), y(diseased)}. Additionally, pr(x, y), pr(x), and pr(y|x) indicate the joint probability of (X, Y) = (x, y), the marginal probability of X = x, and the conditional probability of Y = y given X = x, respectively; similar notation is used for the other probabilities.
In this section, we introduce three representative prevented and preventable fractions: the prevented fraction in the population (PF p ), the prevented fraction among the exposed (PF e ), and the preventable fraction (PaF p ).
In order to evaluate the prevented impact of a protective exposure on the total number of diseases that would be expected if exposure was absent, Miettinen [6] proposed the PF p as
According to Miettinen [6] , PF p is interpreted as "the proportion of cases prevented by the (protective) factor among the totality of cases that would have developed in the absence of the protective factor." Additionally, biostatistical researchers and practitioners may want to evaluate the proportion of potential exposed cases that were prevented by the exposure [6, 14] . Miettinen [6] and Kleinbaum et al. [14] formulated PF e as
Unlike PF p , PF e focuses on the prevented impact of a protective exposure on the expected number of exposed cases that would have developed in the absence of the protective factor [14] . According to Spasoff [15] , PF e is identical to the relative risk reduction that was proposed by Sackett et al. [16] in clinical epidemiology and evaluates how much of the risk is reduced in the exposed group compared with the unexposed group. It is also equivalent to vaccine efficacy, which was originally discussed by Greenwood and Yule [4] in the context of vaccine trials. Although the prevented fraction is frequently referred to as the preventable fraction, these concepts should be distinguished. For example, Boslaugh [12] stated that "With protective risk factors, researchers and policy analysts are often interested in how much of the current disease risk in the total target population is potentially preventable if everyone in the population were exposed. This measure, called the preventable fraction, should be distinguished from the prevented fraction. Whereas the PF p reflects the previous impact of being exposed in the population, the PaF p reflects the potential impact in the future if everyone were to become exposed" [12] .
Porta et al. [11] and other researchers defined PaF p as
which is interpreted as "the proportion of the disease (in the population) that would be prevented if the whole population were exposed to the factor" [11] . To observe the difference between PF p and PaF p , Spasoff [15] considered the hypothetical epidemic in a population in which 40% of subjects had been immunized, and in which the cumulative incidence of the disease was 10% in unimmunized subjects and 2% in immunized subjects, that is, pr(x) = 1 -pr(x ′ ) = 0.400, pr(y|x) = 0.020, pr(y|x ′ ) = 0.100 and pr(y) = pr(y|x)pr(x) + pr(y|x ′ )pr(x ′ ) = 0.068. Then, PF p is given by 0.320, which implies that the immunization program has reduced the incidence of the disease by 32% in the population, that is, the immunization program was 32% effective. By contrast, PaF p is given by 0.706. According to Spasoff [15] , this implies that 71% of diseases could have been prevented by increasing the coverage of the immunization program from 40% to 100%. Although Porta et al. [11] and some researchers introduced the prevented and preventable fractions based on counterfactual concepts, it is unclear how such a concept is introduced into the formulation mathematically. Additionally, it is noted that PF p , PF e and PaF p are formulated based on different target populations: the exposed and unexposed groups. Thus, the traditional prevented and preventable fractions may fall outside the range [0.000, 1.000] without any further assumptions and they cannot be interpreted as proportions. To ensure that these measures are within the range [0.000, 1.000], biostatistical researchers and practitioners often assume that "exposure to a given factor is believed to protect against a disease" [11] , which is supported by negative monotonicity that will be introduced in Section 4.1, or that
holds [2, 6] . However, generally, the former assumption cannot be verified from observed data because the phrase "protect against a disease" conveys much more than statistical association and implies a cause-andeffect relationship between the exposure and the disease. Additionally, when unmeasured confounders exist, the former may not imply the latter and vice versa.
Proposed measures
In this section, we introduce the potential outcome variables that will be used to define the counterfactualbased prevented and preventable proportions.
Preliminaries
In the potential outcome framework [17, 18] , the ith of N subjects has both a potential outcome variable Y x (i) that would have resulted if X had been x, and a potential outcome variable Y x ′ (i) that would have resulted if X had been x ′ . To discuss our problem, this paper assumes the stable unit treatment value assumption (SUTVA), which can be summarized as follows: (i) the exposure status of any subject does not affect the outcomes of the other subjects (non-interference) and (ii) the exposures for all subjects are comparable (no variation in treatment). Thus, when N subjects in a study are considered as random samples from some population, Y x (i) and Y x ′ (i) can be referred to as the values of random variables Y x and Y x ′ , respectively. The causal effect is defined as pr(Y x = y) = pr(y x ), where y x indicates the counterfactual statement that "variable Y would have the value y, had X been x." Additionally, the potential outcome Y x is observed only if X is x, and Y x ′ is observed only if X is x ′ . This is the consistency property [18, 19] , which is formulated as
When a randomized experiment is conducted, X is independent of (Y x , Y x ′ ). This condition is often called exogeneity. Under exogeneity, the causal effect is identifiable and are given by pr(y x ) = pr(y|x), where "identifiable" means that the causal quantities can be consistently estimated from a joint distribution of observed variables. By contrast, when a randomized experiment is difficult to conduct and only observed data is available, we can still identify the causal effect according to the strongly ignorable treatment assignment (SITA) condition [20] or the back-door criterion in the context of graph-based causal inference [18] . That is, for the exposure X, if there exists a set of observed covariates Z such that X is conditionally independent of (Y x , Y x ′ ) given Z, we say that treatment assignment is strongly ignorable given Z, or Z satisfies the SITA condition. Then, the causal effect pr(y x ) is identifiable and is given by
Other than the SITA condition, there are various types of identification conditions for causal effects pr(y x ). For details, refer to Pearl [18] and Tian and Pearl [21] . Finally, because we assume that both X and Y are dichotomous variables, it is noted that there are four possible potential outcome types at the unit-level: (i) a subject who becomes diseased regardless of taking the protective exposure (doomed), that is, {i|(y x (i), y x ′ (i))}; (ii) a subject who does not become diseased only by taking the protective exposure (preventive), that is, {i|(y ′ x (i), y x ′ (i))}; (iii) a subject who does not become diseased only by not taking the protective exposure (causative), that is, {i|(y x (i), y ′ x ′ (i))}; and (iv) a subject who does not become diseased regardless of taking the protective exposure (immune), that is, {i|(y ′
Definition and basic properties 3.2.1 Counterfactual-based prevented proportions (CPPs)
To focus on the prevented impact of a protective exposure on the total number of diseases that would be expected if exposure was absent, we define the counterfactual-based prevented proportion in the population (CPP p ) as
CPP p is interpreted as the proportion of undiseased subjects in the totality of subjects who have a potential outcome type of either "doomed" or "preventive". When we are interested in the prevented impact of a protective exposure on the expected number of exposed cases that would be expected if exposure was absent, we define the counterfactual-based prevented proportion among the exposed (CPP e ) as
CPP e is interpreted as the proportion of undiseased subjects in the group of exposed subjects who have a potential outcome type of either "doomed" or "preventive". Noting that pr(x ′ , y ′ , y x ′ ) = 0 holds from the consistency property, we have
which shows that CPP p does not directly determine CPP e (and vice versa) and that they are not entirely independent of each other. Additionally, eq. (9) shows that CPP e over-evaluates CPP p . Because we have pr(x, y x ′ ) = pr(y x ′ ) -pr(x ′ , y) from the consistency property, we obtain
Thus, under the condition of pr(y x ′ ) ≠ pr(x ′ , y), pr(x ′ , y) = 0 implies CPP p = CPP e . Finally, under exogeneity, we have CPP p = pr(x)CPP e and CPP e = pr(y
Counterfactual-based preventable proportions (CPaPs)
To propose the counterfactual measure corresponding to the PaF, we pay attention to the following two aspects: (i) the attributable proportions in the population and among the exposed are formulated as pr(y ′ x ′ |y) and pr(y ′ x ′ |x, y) respectively [13] and (ii) the description PaF p (preventable fraction) is equivalent to the population attributable fraction (AF p ) in which "exposed" and "unexposed" categories are reversed [12] . We define the counterfactual-based preventable proportions in the population (CPaP p ) and among the unexposed (CPaP u ) as 
respectively. CPaP p can be considered as analogical measures of "probability of enablement" and "probability of disablement" [18, 24] . In addition, CPaP u can be regarded as analogical measures of "probability of necessity" and "probability of sufficiency" discussed in the context of "probabilities of causation" [18, [23] [24] [25] [26] . Then, from the consistency property, we have
( 1 4 ) Thus, under the condition pr(x ′ , y) ≠ 0, from eq. (14), pr(x, y) = 0 implies CPaP p = CPaP u . Additionally, under exogeneity, we have
4 Identification and bounds
Identification
CPP p , CPP e , CPaP p and CPaP u involve probabilities of potential outcomes; therefore they are not identifiable from observed data without any further assumptions regarding the data generating process. In this section, under negative monotonicity, that is,
when causal effects pr(y x ) and observed probabilities pr(x, y) are available, we show that CPP p , CPP e , CPaP p and CPaP u are identifiable. Negative monotonicity is an important assumption in the discussion of prevented and preventable fractions because it supports the assumption that "exposure to a given factor is believed to protect against a disease" [11] and leads to
Additionally, negative monotonicity, together with exogeneity, connects such an assumption with eq. (4) [2, 6] . We note that eq. (17) does not imply negative monotonicity. When both causal effects and observed probabilities are available, under negative monotonicity, we have
Importantly, under negative monotonicity and the exogeneity assumption, because we have pr(y x ) =pr(y|x), we derive 
Bounds
Generally, even if both causal effects and observed probabilities are available, eqs. (7), (8) and (13) are not identifiable without any further assumptions. Thus, one possible solution is to derive the closed-form formulas of the bounds on these measures. To derive the bounds, we use the idea from Tian and Pearl's bounds [26] for the probabilities of causation. According to Tian and Pearl [26] , when both pr(y x ) and pr(x, y) are available without any further assumptions, we have
. ( 2 6 ) Regarding CPP p , from eq. (25), we have
When pr(x, y ′ ) = 0 or pr(y x ′ ) = pr(x ′ , y), CPP p equals zero. When pr(x, y) = 0 or pr(y ′ x ′ ) = pr(x ′ , y ′ ), we have
Additionally, regarding CPaP p , from eq. (26), we have
When pr(x ′ , y) = 0 or pr(y ′ x ) = pr(x, y ′ ), CPaP p equals zero. When pr(x ′ , y ′ ) = 0 or pr(y x ) = pr(x, y), we have
Regarding the bounds on CPP e and CPaP u , by replacing pr(y x ′ ) and pr(y) in their denominators with pr(y x ′ ) -pr(x ′ , y) and pr(x ′ , y), respectively, we have
Here, under the exogeneity assumption, because we have pr(y x ) =pr(y|x), these bounds show that CPP p , CPaP p and CPP e are not lower than PF p , PaF p and PF e , respectively. One of our idea to derive the narrower bounds than eqs. (27), (29), (31) and (32) is to use the covariate information measured in experimental and observational studies. For the procedure to derive the narrower bounds, refer to Kuroki and Cai [23] and Cai et al. [27, 28] . Another idea is to introduce causal assumptions to derive the narrower bound. For example, as different assumptions from negative monotonicity, that is, eq. (16), we consider the group-level negative monotone treatment response (negative MTR) assumptions for exposed and unexposed groups, that is,
The assumption is derived from the unit-level negative MTR assumptions for exposed and unexposed groups, that is, for x and
for each unit i in both exposed and unexposed groups [29, 30] . Here, eqs. (33) provide the inequalities pr(x, y, y
Although both pr(y x ′ ) -pr(y) and pr(y ′ x ) -pr(y ′ ) can take negative values without any further assumption, under eqs. (35), they take non-negative values, and the lower bounds on pr(x, y ′ , y x ′ ) and pr(x ′ , y, y ′ x ) are evaluated by pr(y x ′ ) -pr(y) and pr(y ′ x ) -pr(y ′ ) respectively. When we assume negative monotonicity, since we have
we derive
and
Here, the bounds on CPP e are given by
but the bounds on CPaP u provide no information in the sense that they are given by the range [0.000, 1.000] from
Finally, when only pr(x, y) is available, without any further assumptions, the bounds on CPP p and CPaP p are given by
respectively, from eqs. (27), (29) and
.
The bounds on CPP e and CPaP u provide no information in the sense that they are given by the range [0.000, 1.000].
The results of this section are summarized in Table 1 under the assumption that observed probabilities are available, where "+" signifies that the corresponding assumption holds and "-" is used otherwise.
Conclusion
The idea of prevented and preventable fractions has been widely applied in medical science to evaluate how much of a disease could be averted by a protective exposure for subjects that would have become diseased in the absence of the exposure. However, the traditional formulas used in practical situations have a drawback, which is that they cannot be interpreted as proportions without any further assumptions because they are formulated based on different target populations and may fall outside the range [0.000, 1.000]. To solve this problem, when both the exposure and outcome are dichotomous, we proposed four types of new measures of potential impact based on the potential outcome model. The proposed measures are proportions: they are defined based on a single target population and are always within the range [0.000, 1.000]. When both causal effects and observed probabilities are available, this paper showed that the proposed measures are identifiable under the negative monotonicity assumption. The negative monotonicity assumption can be considered as a causal assumption to justify "exposure to a given factor is believed to protect against a disease" [11] . Additionally, when negative monotonicity is violated, we formulated the bounds on the proposed measures. Furthermore, we showed that negative monotonicity together with exogeneity induces equivalence between the proposed measures and existing measures. Therefore, the proposed measures are helpful for biostatistical researchers and practitioners to assess what percentage of a disease could be averted by a protective exposure for cases that would have become diseased in the absence of the exposure.
Appendices
A. Application
A.1 Experimental Study
In this appendix, we apply our results to data from a randomized trial conducted in Guangxi, China, to test the efficacy of locally produced Vi vaccine. According to Levine [31] and Yang et al. [32] , in this trial, 65,287 subjects received a 30-,g dose of Vi vaccine (X = x) and 65,984 controls received a saline dose (X = x ′ ). At the time of vaccination, 92% of subjects were children aged between 5 and 19. During 19 months of follow-up, 7 cases of blood culture-confirmed typhoid fever (Y = y) were detected among the vaccinated compared with 23 confirmed cases among the controls, thus demonstrating a vaccine efficacy of 69%. For further details, refer to Levine [31] and Yang et al. [32] .
Based on the discussion in Section 4, we evaluate CPP p , CPP e , CPaP p and CPaP u of Vi vaccine on typhoid fever. Noting that the data are obtained from a randomized trial, we have pr(y x ) = pr(y|x) = 7/65, 287, pr(y Table 2 .
A.2 Observational Study
In this appendix, we apply our results to data from the INTERHEART study which was conducted by Yusuf et al. [33] and reanalyzed by Walter [34] . The aim of this observational study was to evaluate the effect of potentially modifiable risk factors on acute myocardial infarction in 52 countries. In this study, based on the population attributable risks (PAR), various risk factors were studied, including smoking, history of hypertension or diabetes, waist/hip ratio, dietary patterns, physical activity, consumption of alcohol, blood apolipoproteins, and psychosocial factors to acute myocardial infarction. For details, refer to Yusuf et al. [33] and Walter [34] . Following Walter [34] , we use data on smoking status from 10 world regions, shown in Table  3 , and evaluate proposed measures. First, we assume that the world region (Z) is a sufficient confounder between smoking status (X) and acute myocardial infarction (Y), that is, Z satisfies the SITA condition, where smoking status consists of "never smoke" (protective exposure; X = x) and "ever (former or current) smoke" (non-protective exposure; X = x ′ ). Then, based on the discussion in Section 4, we evaluate CPP p , CPP e , CPaP p and CPaP u of smoking on acute myocardial infarction. Because we assume that the world region (Z) is a sufficient confounder, the causal effects of X = x on Y = y and of X = x ′ on Y = y are given by pr(y x ) = 0.359 and pr(y x ′ ) = 0.535 respectively. Thus, the bounds on CPP 
B. Extension to Multi-Categorical Exposure Cases
Here, we consider the case where X is a multi-categorical protective exposure that takes the value x ∈ {x 0 , x 1 , ..., x l } and Y is a dichotomous response variable.
B.1 Counterfactual-Based Prevented Proportions
Regarding CPP e , we extend eq. (8) 
which is also discussed by Miettinen [6] as prevented fraction "for a polytomous indicator of protection." Generally, even if a randomized experiment is conducted, eq. (42) is not identifiable without any further assumptions. Thus, to solve the problem, we formulate the closed-form formulas of the bounds on these measures. First, when both pr(y x |x ′ ) and pr(x, y) are available without any further assumptions (x ≠ x ′ ; x, x ′ ∈ {x 0 , ..., 
The bounds on CPaP k u provide no information in the sense that they are given by the range [0.000, 1.000].
